Surveillance to Track Progress Toward Polio Eradication — Worldwide, 2017–2018
2019; Centers for Disease Control and Prevention; Volume: 68; Issue: 13 Linguagem: Inglês
10.15585/mmwr.mm6813a4
ISSN1545-861X
AutoresJaymin C. Patel, Ousmane M. Diop, Tracie J. Gardner, Smita Chavan, Jaume Jorba, Steven G. F. Wassilak, Jamal Ahmed, Cynthia J. Snider,
Tópico(s)Whipple's Disease and Interleukins
ResumoWhen the Global Polio Eradication Initiative (GPEI) began in 1988, cases of poliomyelitis were reported from 125 countries. Since then, only Afghanistan, Nigeria, and Pakistan have experienced uninterrupted transmission of wild poliovirus (WPV). The primary means of detecting poliovirus is through surveillance for acute flaccid paralysis (AFP) among children aged <15 years with testing of stool specimens for WPV and vaccine-derived polioviruses (VDPVs) in World Health Organization (WHO)-accredited laboratories of the Global Polio Laboratory Network (GPLN) (1,2). AFP surveillance is supplemented by environmental surveillance for polioviruses in sewage at selected locations. Analysis of genomic sequences of isolated polioviruses enables assessment of transmission by time and place, potential gaps in surveillance, and emergence of VDPVs (3). This report presents 2017-2018 poliovirus surveillance data, focusing on 31 countries* identified as high-priority countries because of a "high risk of poliovirus transmission and limited capacity to adequately address those risks" (4). Some of these countries are located within WHO regions with endemic polio, and others are in regions that are polio-free. In 2018, 26 (84%) of the 31 countries met AFP surveillance indicators nationally; however, subnational variation in surveillance performance was substantial. Surveillance systems need continued strengthening through monitoring, supervision, and improvements in specimen collection and transport to provide sufficient evidence for interruption of poliovirus circulation.
Referência(s)